1. Home
  2. Labeler Index
  3. Ascend Laboratories, Llc
  4. 67877-882
  5. NDC Package Code: 67877-882-71 Rivaroxaban

NDC Package 67877-882-71 Rivaroxaban

Granule, For Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67877-882-71
Package Description:
1 BOTTLE in 1 CARTON / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE
Product Code:
67877-882
Proprietary Name:
Rivaroxaban
Non-Proprietary Name:
Rivaroxaban
Substance Name:
Rivaroxaban
Usage Information:
Rivaroxaban is used to prevent blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip or knee replacement surgery. It is also used to prevent blood clots from forming in high-risk patients with limited mobility during their hospital stay and after discharge. In addition, rivaroxaban is used to treat blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE) and to prevent the blood clots from forming again. Rivaroxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.
11-Digit NDC Billing Format:
67877088271
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Ascend Laboratories, Llc
Dosage Form:
Granule, For Suspension - A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
RIVAROXABAN 155 mg/1
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA218502
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
07-07-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67877-882-71?

The NDC Packaged Code 67877-882-71 is assigned to a package of 1 bottle in 1 carton / 1 granule, for suspension in 1 bottle of Rivaroxaban, a human prescription drug labeled by Ascend Laboratories, Llc. The product's dosage form is granule, for suspension and is administered via oral form.

Is NDC 67877-882 included in the NDC Directory?

Yes, Rivaroxaban with product code 67877-882 is active and included in the NDC Directory. The product was first marketed by Ascend Laboratories, Llc on July 07, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 67877-882-71?

The 11-digit format is 67877088271. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-267877-882-715-4-267877-0882-71